Further research has found that EA can increase the expression level of tissue inhibitors of metalloproteinases (TIMP-1), downregulate the expression of MMP-9, reduce the MMP-9/TIMP-1 ratio, and protect the integrity of the extracellular matrix (ECM), thereby inhibiting tumor metastasis. The gene discussed is MMP9; the disease is neoplasm.